Logo
x

Search

Subscribe Now

bevacizumab

Amneal Reports the US FDA's Acceptance of BLA for Alymsys (biosimilar- bevacizumab)

Amneal Reports the US FDA's Acceptance of BLA for Alymsys (biosimilar- bevacizumab)

  • June 17, 2021
Henlius Presents P-III Data of HLX04 (biosimilar- bevacizumab) at CSCO 2020

Henlius Presents P-III Data of HLX04 (biosimilar- bevacizumab) at CSCO 2020

  • September 20, 2020
Samsung Bioepis to Present P-III Exploratory Analyses Results of Aybintio (bevacizumab- biosimilar) at ESMO 2020

Samsung Bioepis to Present P-III Exploratory Analyses Results of Aybintio (bevacizumab- biosimilar) at ESMO 2020

  • September 17, 2020
Henlius Reports NMPA's Acceptance of NDA for HLX04 (biosimilar- bevacizumab)

Henlius Reports NMPA's Acceptance of NDA for HLX04 (biosimilar- bevacizumab)

  • September 11, 2020
BeiGene Signs a License and Supply Agreement with Bio-Thera for BAT1706 (biosimilar- bevacizumab) in China

BeiGene Signs a License and Supply Agreement with Bio-Thera for BAT1706 (biosimilar- bevacizumab) in China

  • August 25, 2020
Samsung Bioepis' Aybintio (SB8- biosimilar- bevacizumab) Receives the EC's Approval for Launch in EU

Samsung Bioepis' Aybintio (SB8- biosimilar- bevacizumab) Receives the EC's Approval for Launch in EU

  • August 21, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.